The P2X7 purinergic receptor: An emerging therapeutic target in cardiovascular diseases
Zhe Chen1, Lu He1, Lanfang Li1
1Institute of Pharmacy and Pharmacology, University of South China, Hengyang 421001, China.
Abstract:
The P2X7 purinergic receptor, a calcium permeable cationic channel, is activated by extracellular ATP. Most studies show that P2X7 receptor plays an important role in the nervous system diseases, immune response, osteoporosis and cancer. Mounting evidence indicates that P2X7 receptor is also associated with cardiovascular disease. For example, the P2X7 receptor activated by ATP can attenuate myocardial ischemia-reperfusion injury. By contrast, inhibition of P2X7 receptor decreases arrhythmia after myocardial infarction, prolongs cardiac survival after a long term heart transplant, alleviates the dilated cardiomyopathy and the autoimmune myocarditis process. The P2X7 receptor also mitigates vascular diseases including atherosclerosis, hypertension, thrombosis and diabetic retinopathy. This review focuses on the latest research on the role and therapeutic potential of P2X7 receptor in cardiovascular diseases.
Insights
The P2X7 receptor, a key player in cell signaling, impacts cardiovascular health. Research explores its dual role in conditions like heart attack and atherosclerosis, highlighting its therapeutic potential.
Area of Science:
- Cardiovascular Research
- Molecular Biology
- Immunology
Background:
- The P2X7 receptor is an ATP-gated ion channel involved in various physiological processes.
- Its role in cardiovascular diseases is increasingly recognized, with evidence suggesting both protective and detrimental effects.
- Understanding P2X7 receptor function is crucial for developing novel cardiovascular therapies.
Purpose of the Study:
- To review the latest research on the P2X7 receptor's involvement in cardiovascular diseases.
- To explore the therapeutic potential of targeting the P2X7 receptor for cardiovascular conditions.
Main Methods:
- Literature review of studies investigating P2X7 receptor in cardiovascular contexts.
- Analysis of experimental data on P2X7 receptor activation and inhibition in models of cardiovascular disease.
Main Results:
- P2X7 receptor activation can attenuate myocardial ischemia-reperfusion injury.
- Inhibition of P2X7 receptor shows benefits in arrhythmia, cardiac transplantation, cardiomyopathy, and autoimmune myocarditis.
- The P2X7 receptor influences vascular diseases such as atherosclerosis, hypertension, thrombosis, and diabetic retinopathy.
Conclusions:
- The P2X7 receptor has a significant and complex role in cardiovascular health and disease.
- Targeting the P2X7 receptor presents a promising therapeutic avenue for various cardiovascular and vascular conditions.
Related Concept Videos
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Cardiovascular Drugs: Classification based on Therapeutic Indications
Emerging Adulthood
Internal Receptors
Overview of the Cardiovascular System
Heart
The heart is the central pump of the cardiovascular system that circulates blood throughout the body. It comprises two atria receiving the blood and two ventricles pumping blood out of the heart. Their rhythmic contractions, called heartbeats, ensure that blood flow remains continuous.
Blood Vessels
Blood...
Introduction Cardiac Emergencies


